The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
The U.S. Food and Drug Administration's Mini‐Sentinel program: status and direction
Open accessAbstract
The Mini‐Sentinel is a pilot program that is developing methods, tools, resources, policies, and procedures to facilitate the use of routinely collected electronic healthcare data to perform active surveillance of the safety of marketed medical products, including drugs, biologics, and medical devices. The U.S. Food and Drug Administration (FDA) initiated the program in 2009 as part of its Sentinel Initiative, in response to a Congressional mandate in the FDA Amendments Act of 2007. After two years, Mini‐Sentinel includes 31 academic and private organizations. It has developed policies, procedures, and technical specifications for developing and operating a secure distributed data system comprised of separate data sets that conform to a common data model covering enrollment, demographics, encounters, diagnoses, procedures, and ambulatory dispensing of prescription drugs. The distributed data sets currently include administrative and claims data from 2000 to 2011 for over 300 million person‐years, 2.4 billion encounters, 38 million inpatient hospitalizations, and 2.9 billion dispensings. Selected laboratory results and vital signs data recorded after 2005 are also available. There is an active data quality assessment and characterization program, and eligibility for medical care and pharmacy benefits is known. Systematic reviews of the literature have assessed the ability of administrative data to identify health outcomes of interest, and procedures have been developed and tested to obtain, abstract, and adjudicate full‐text medical records to validate coded diagnoses. Mini‐Sentinel has also created a taxonomy of study designs and analytical approaches for many commonly occurring situations, and it is developing new statistical and epidemiologic methods to address certain gaps in analytic capabilities. Assessments are performed by distributing computer programs that are executed locally by each data partner. The system is in active use by FDA, with the majority of assessments performed using customizable, reusable queries (programs). Prospective and retrospective assessments that use customized protocols are conducted as well. To date, several hundred unique programs have been distributed and executed. Current activities include active surveillance of several drugs and vaccines, expansion of the population, enhancement of the common data model to include additional types of data from electronic health records and registries, development of new methodologic capabilities, and assessment of methods to identify and validate additional health outcomes of interest. Copyright © 2012 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jensen, P. N., Johnson, K., Floyd, J., Heckbert, S. R., Carnahan, R., & Dublin, S. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2317 · Cited by 339
Self-citationDeveloping the Sentinel System — A National Resource for Evidence Development
Behrman, R. E., Benner, J. S., Brown, J. S., McClellan, M., Woodcock, J., & Platt, R. (2011) · New England Journal of Medicine · doi:10.1056/nejmp1014427 · Cited by 323
Self-citationEffects of Adjusting for Instrumental Variables on Bias and Precision of Effect Estimates
Myers, J. A., Rassen, J. A., Gagne, J. J., Huybrechts, K. F., Schneeweiss, S., Rothman, K. J., Joffe, M. M., & Glynn, R. J. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr364 · Cited by 291
Self-citationA systematic review of validated methods for identifying heart failure using administrative data
Saczynski, J. S., Andrade, S. E., Harrold, L. R., Tjia, J., Cutrona, S. L., Dodd, K. S., Goldberg, R. J., & Gurwitz, J. H. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2313 · Cited by 278
Andrade, S. E., Harrold, L. R., Tjia, J., Cutrona, S. L., Saczynski, J. S., Dodd, K. S., Goldberg, R. J., & Gurwitz, J. H. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2312 · Cited by 268
The New Sentinel Network — Improving the Evidence of Medical-Product Safety
Platt, R., Wilson, M., Chan, K. A., Benner, J. S., Marchibroda, J., & McClellan, M. (2009) · New England Journal of Medicine · doi:10.1056/nejmp0905338 · Cited by 228
Self-citationDesign considerations, architecture, and use of the Mini‐Sentinel distributed data system
Curtis, L. H., Weiner, M. G., Boudreau, D. M., Cooper, W. O., Daniel, G. W., Nair, V. P., Raebel, M. A., Beaulieu, N. U., Rosofsky, R., Woodworth, T. S., et al. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2336 · Cited by 224
Self-citationGuidelines for good database selection and use in pharmacoepidemiology research
Hall, G. C., Sauer, B., Bourke, A., Brown, J. S., Reynolds, M. W., & Casale, R. L. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2229 · Cited by 198
Self-citationTamariz, L., Harkins, T., & Nair, V. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2341 · Cited by 197
Invited Commentary: Understanding Bias Amplification
Pearl, J. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr352 · Cited by 189
When should case‐only designs be used for safety monitoring of medical products?
Maclure, M., FIREMAN, B. H., Nelson, J. C., Hua, W., Shoaibi, A., Paredes, A., & Madigan, D. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2330 · Cited by 145
Self-citationWalkup, J. T., Townsend, L. D., Crystal, S., & Olfson, M. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2335 · Cited by 133
Robb, M. A., Racoosin, J. A., Sherman, R. E., Gross, T. P., Ball, R., Reichman, M. E., Midthun, K., & Woodcock, J. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2311 · Cited by 118
Self-citationA systematic review of validated methods for identifying depression using administrative data
Townsend, L. D., Walkup, J. T., Crystal, S., & Olfson, M. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2310 · Cited by 104
Nguyen, M., Ball, R., Midthun, K., & Lieu, T. A. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2323 · Cited by 103
Rassen, J. A., & Schneeweiß, S. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2328 · Cited by 101
Kee, V. R., Gilchrist, B., Granner, M. A., Sarrazin, N. R., & Carnahan, R. M. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2329 · Cited by 100
Self-citationTamariz, L. J., Harkins, T. P., & Nair, V. P. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2340 · Cited by 82
Carnahan, R. M. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2318 · Cited by 75
Self-citationA policy framework for public health uses of electronic health data
McGraw, D., Rosati, K., & Evans, B. J. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2319 · Cited by 68
Forrow, S., Campion, D. M., Herrinton, L. J., Nair, V. P., Robb, M. A., Wilson, M., & Platt, R. G. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2242 · Cited by 58
Self-citationNelson, J. C., Cook, A. J., Yu, O., Dominguez, C., Zhao, S., Greene, S. K., FIREMAN, B. H., Jacobsen, S. J., Weintraub, E., & Jackson, L. A. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2324 · Cited by 56
Self-citationDesign considerations in an active medical product safety monitoring system.
Gagne, J. J., Fireman, B., Ryan, P. B., Maclure, M., Gerhard, T., Toh, S., Rassen, J. A., Nelson, J. C., & Schneeweiss, S. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2316 · Cited by 49
Self-citationCook, A. J., Tiwari, R. C., Wellman, R., Heckbert, S. R., Li, L., Heagerty, P. J., Marsh, T. L., & Nelson, J. C. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2320 · Cited by 48
Self-citationA systematic review of validated methods for identifying pancreatitis using administrative data
Moores, K. G., Gilchrist, B., Carnahan, R. M., & Abrams, T. E. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2334 · Cited by 39
Self-citationDesign for validation of acute myocardial infarction cases in Mini‐Sentinel
Cutrona, S. L., Toh, S., Iyer, A., Foy, S., Cavagnaro, E., Forrow, S., Racoosin, J. A., Goldberg, R. J., & Gurwitz, J. H. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2314 · Cited by 38
Self-citationFIREMAN, B. H., Toh, S., Butler, M. G., Go, A. S., Joffe, H. V., Graham, D. J., Nelson, J. C., Daniel, G. W., & Selby, J. V. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2337 · Cited by 38
Self-citationSchneider, G., Kachroo, S., Jones, N. B., Crean, S. M., Rotella, P., Avetisyan, R., & Reynolds, M. W. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2327 · Cited by 31
The U.S. Food and Drug Administration's Mini‐Sentinel Program
Platt, R. G., & Carnahan, R. M. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3230 · Cited by 29
Self-citationA systematic review of validated methods for identifying lymphoma using administrative data
Herman, R. A., Gilchrist, B., Link, B. K., & Carnahan, R. M. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2315 · Cited by 27
Self-citationSchneider, G., Kachroo, S., Jones, N. B., Crean, S. M., Rotella, P., Avetisyan, R., & Reynolds, M. W. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2333 · Cited by 19
Carnahan, R. M., Moores, K. G., & Perencevich, E. N. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2332 · Cited by 9
Self-citation
Cited by
Tuppin, P., Rudant, J., Constantinou, P., Gastaldi-Ménager, C., Rachas, A., de Roquefeuil, L., Maura, G., Caillol, H., Tajahmady, A., Coste, J., et al. (2017) · Revue d'Épidémiologie et de Santé Publique · doi:10.1016/j.respe.2017.05.004 · Cited by 891
Bezin, J., Duong, M., Lassalle, R., Droz, C., Pariente, A., Blin, P., & Moore, N. (2017) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4233 · Cited by 584
Big data analytics to improve cardiovascular care: promise and challenges
Rumsfeld, J. S., Joynt, K. E., & Maddox, T. M. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.42 · Cited by 398
Intussusception Risk after Rotavirus Vaccination in U.S. Infants
Yih, W. K., Lieu, T. A., Kulldorff, M., Martin, D., McMahill-Walraven, C. N., Platt, R., Selvam, N., Selvan, M., Lee, G. M., & Nguyen, M. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1303164 · Cited by 318
Self-citationPrivacy-Preserving Patient Similarity Learning in a Federated Environment: Development and Analysis
Lee, J., Sun, J., Wang, F., Wang, S., Jun, C.-H., & Jiang, X. (2018) · JMIR Medical Informatics · doi:10.2196/medinform.7744 · Cited by 196
Metadata
- Authors
- Platt, R., Carnahan, R. M., Brown, J. S., Chrischilles, E., Curtis, L. H., Hennessy, S., Nelson, J. C., Racoosin, J. A., Robb, M., Schneeweiss, S., Toh, S., & Weiner, M. G.
- Venue
- Pharmacoepidemiology and Drug Safety
- Publisher
- Wiley
- Published
- 2012-01
- Volume
- 21
- Issue
- S1
- Pages
- 1-8
- ISSN
- 1053-8569 (ISSN-L)
- 1099-1557
- OpenAlex
- W1594888675
- Cited by
- 287
- References
- 32
- FWCI
- 52.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.